| Q2 2024 |
18 |
$1.08B |
+$63.3M |
-$192M |
-$129M |
EGO, VIST, CAAP, YPF, VEON
|
13F-HR |
7/30/2024, 01:33 PM |
| Q1 2024 |
17 |
$1.16B |
+$134M |
-$142M |
-$8.53M |
EGO, VIST, YPF, CAAP, IAG
|
13F-HR |
4/18/2024, 12:44 PM |
| Q4 2023 |
15 |
$1.02B |
+$104M |
-$96.7M |
+$6.91M |
EGO, YPF, VIST, CAAP, VEON
|
Restatement |
2/12/2024, 01:22 PM |
| Q3 2023 |
14 |
$799M |
+$75.1M |
-$46.1M |
+$29M |
EGO, VIST, YPF, CAAP, CGAU
|
13F-HR |
10/31/2023, 11:58 AM |
| Q2 2023 |
15 |
$819M |
+$85.6M |
-$30.6M |
+$55M |
EGO, YPF, VIST, CAAP, CGAU
|
13F-HR |
7/28/2023, 11:42 AM |
| Q1 2023 |
12 |
$748M |
+$134M |
-$21M |
+$113M |
EGO, YPF, CAAP, CGAU, VIST
|
13F-HR |
5/9/2023, 10:24 AM |
| Q4 2022 |
8 |
$532M |
+$91.5M |
-$18.1M |
+$73.5M |
EGO, CGAU, CAAP, YPF, PBRA
|
13F-HR |
2/3/2023, 10:24 AM |
| Q3 2022 |
6 |
$341M |
+$114M |
|
+$114M |
EGO, CGAU, CAAP, YPF, VIST
|
13F-HR |
11/8/2022, 09:01 AM |
| Q2 2022 |
4 |
$253M |
+$34.3M |
-$5.63M |
+$28.7M |
EGO, CGAU, CAAP, VIST
|
13F-HR |
7/19/2022, 08:48 AM |
| Q1 2022 |
6 |
$333M |
+$12.6M |
-$53.6M |
-$41M |
EGO, CGAU, CAAP, VIST, VEONXXXX
|
13F-HR |
4/26/2022, 09:36 AM |
| Q4 2021 |
4 |
$315M |
+$4.03M |
-$84.5M |
-$80.5M |
EGO, CGAU, CAAP, VEONXXXX
|
13F-HR |
1/18/2022, 09:30 AM |
| Q3 2021 |
3 |
$343M |
+$50.3M |
-$12M |
+$38.4M |
EGO, CGAU, CAAP
|
13F-HR |
10/20/2021, 12:42 PM |
| Q2 2021 |
4 |
$359M |
+$152M |
-$12.5M |
+$139M |
EGO, CGAU, CAAP, ADN
|
13F-HR |
8/2/2021, 01:33 PM |
| Q1 2021 |
3 |
$231M |
+$113M |
-$26M |
+$86.6M |
EGO, CAAP, ADN
|
13F-HR |
5/17/2021, 01:41 PM |
| Q4 2020 |
4 |
$155M |
|
|
|
EGO, CAAP, HTOO, HTOOW
|
13F-HR |
2/3/2021, 08:44 AM |